1 June 2020

Contents

Editorial

• HIV and COVID-19: issue 4 (1 June 2020)

In memory

• Dr Ron Simmons. Activist. Teacher. Mentor. Organiser. Leader. Survivor. Black gay icon.

• Larry Kramer, playwright, AIDS activist and writer  (1935-2020)

HIV prevention and transmission

• Cabotegravir long-acting injections prevent HIV as PrEP

COVID-19: HIV and COVID-19 coinfection

• HIV and COVID-19 coinfection: case reports, retrospective cohorts and outcomes

COVID-19: treatment access

• UK access to remdesivir approved: but MHRA criteria exclude some who could benefit

• EMA recommends expanding access to remdesivir

COVID-19: investigational drugs

• Remdesivir improves recovery time in early COVID-19 infection: first definitive results of benefit

• Convalescent plasma therapy for COVID-19

• Treatment with interferon in early COVID-19

• Famotidine associated with improved clinical outcomes in people hospitalised with COVID-19

• Tocilizumab and remdesivir in new dual therapy study

• RETRACTED – Re: No benefit from hydroxychloroquine, with or without macrolide antibiotics in analysis of 96,000 participants

COVID-19: pathogenesis

• Changes in taste and smell as symptoms of COVID-19

• Low CD4s and CD8s – but not viral genetics – predict COVID-19 progression

• Autopsies show how COVID-19 damages lungs more than flu

COVID-19: guidelines

• BHIVA advice for HIV positive people hospitalised with COVID-19

• BHIVA guidelines on shielding: advice for HIV clinicians, GPs and people living with HIV

• European consensus on HIV and COVID-19: UK (BHIVA), European (EACS), Spanish, German and Polish HIV organisations

• UK guidelines for the treatment of COVID-19: UK prioritises 42 studies

PDFs

• HIV and COVID-19 bulletin no 4 (1 June 2020)